Tag: questionnaires

Hivelocity Launches SaaS Bundle – Cloud Workflow, Bare Metal Economics, Predictable Bill

A three-tier bundle spanning Engineering, Production, and Hi-Scale Compute puts the steady-state SaaS stack on dedicated hardware priced for sustained load, with cloud workflow...

Ryght AI Partners with Global CRO Biorasi to Deliver AI-Powered Feasibility Solutions to Biotech and Biopharma Sponsors

Advanced AI Platform Enables More Accurate Site Selection and Faster Study Startup Across Key Therapeutic Areas Partnership brings real-time site identification, feasibility, activation and automated...

Angle Health Partners with PerfectQuote to Revolutionize Level Funded Health Plan Quoting with Industry’s First Real-Time Underwritten Rates

Group Health Life and Benefits Brokers can leverage PerfectQuote's Digital Quoting Platform to receive firm, underwritten level funded quotes directly from Angle Health in...

Primary school children’s art reveals real-world impact of learning English, new study

A new study from Cambridge shows the diverse motivations young people have for learning English, brought to life through a series of drawings by...

Freya Pharma Solutions Announces Launch of Phase II Clinical Dose-Response Study testing its LybridoTM Concept Targeting Female Sexual Dysfunction

www.freyapharmasolutions.com

Two-Year Real-World Study of LEQEMBI® in the United States Presented at Alzheimer’s Association International Conference (AAIC) 2025

TOKYO and CAMBRIDGE, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the two-year real-world study in the U.S of lecanemab (generic name, product name: LEQEBMI^®), an anti-Aβ protofibril* antibody, was presented at the Alzheimer's Association International Conference (AAIC) 2025, held in Toronto, Canada and virtually. Only lecanemab fights AD in two ways – targeting both amyloid plaque and protofibrils*, which can impact tau downstream.

Corbion receives strong sustainability ratings in multiple categories from CDP

Global ingredient supplier Corbion has once again demonstrated its strong commitment to sustainability, earning high marks in climate, water, and supplier engagement in CDP’s Disclosure Cycle 2024.

Abinopharm, Inc. and EGT Synbio Announce Successful Human Clinical Trials on Oral L-Ergothioneine (Dr.Ergo®) for Skin Health

Human Clinical Trial of L-Ergothioneine (Dr.Ergo®) on Skin Health

Sleep Apnea Market to Accelerate Substantially at a CAGR of 20% During the Study Period (2020-2034) | DelveInsight

The sleep apnea market growth is driven by rising awareness, technological advancements, and demand for personalized care. Companies innovate therapies and solutions for better...

Institute for Governance & Markets: Survey Reveals Growing Frustration Among Co-op Shareholders Over Glanbia Governance

Institute for Governance & Markets releases preliminary findings from member surveys and launches nationwide study. DUBLIN, June 24, 2025 /PRNewswire/ -- The Institute for Governance...

SeAH Aerospace & Defense Receives Boeing’s Supplier Production Partner Award for Excellence in Aerospace Materials

Insta360 Launches Luna Ultra: Leica Co-Engineered Gimbal Camera Built for Next-Generation Mobile Filmmaking

ToolGen Opens Advanced Field Testing Facility in Osong, Completing ‘Bench-to-Field’ Commercialization Platform for Global SAF and Industrial Crop Markets

Tag: questionnaires

Hivelocity Launches SaaS Bundle – Cloud Workflow, Bare Metal Economics, Predictable Bill

Ryght AI Partners with Global CRO Biorasi to Deliver AI-Powered Feasibility Solutions to Biotech and Biopharma Sponsors

Angle Health Partners with PerfectQuote to Revolutionize Level Funded Health Plan Quoting with Industry’s First Real-Time Underwritten Rates

Primary school children’s art reveals real-world impact of learning English, new study

Freya Pharma Solutions Announces Launch of Phase II Clinical Dose-Response Study testing its LybridoTM Concept Targeting Female Sexual Dysfunction

Two-Year Real-World Study of LEQEMBI® in the United States Presented at Alzheimer’s Association International Conference (AAIC) 2025

Corbion receives strong sustainability ratings in multiple categories from CDP

Abinopharm, Inc. and EGT Synbio Announce Successful Human Clinical Trials on Oral L-Ergothioneine (Dr.Ergo®) for Skin Health

Sleep Apnea Market to Accelerate Substantially at a CAGR of 20% During the Study Period (2020-2034) | DelveInsight

Institute for Governance & Markets: Survey Reveals Growing Frustration Among Co-op Shareholders Over Glanbia Governance

Explore

Press Releases

News & Opinion

Living

Others

Follow us